Access the full text.
Sign up today, get DeepDyve free for 14 days.
N. Chau, G. Rabinowits, R. Haddad (2014)
Human Papillomavirus-Associated Oropharynx Cancer (HPV-OPC): Treatment OptionsCurrent Treatment Options in Oncology, 15
C. Ragin, E. Taioli (2007)
Survival of squamous cell carcinoma of the head and neck in relation to human papillomavirus infection: Review and meta‐analysisInternational Journal of Cancer, 121
K. Ang, J. Harris, R. Wheeler, R. Weber, David Rosenthal, P. Nguyen-Tan, William Westra, Christine Chung, Richard Jordan, Charles Lu, Harold Kim, R. Axelrod, C. Silverman, Kevin Redmond, Maura Gillison (2010)
Human papillomavirus and survival of patients with oropharyngeal cancer.The New England journal of medicine, 363 1
E. Vokes, T. Seiwert (2013)
EGFR-directed treatments in SCCHN.The Lancet. Oncology, 14 8
M. Posner, J. Lorch, O. Goloubeva, M. Tan, L. Schumaker, N. Sarlis, R. Haddad, K. Cullen (2011)
Survival and human papillomavirus in oropharynx cancer in TAX 324: a subset analysis from an international phase III trial.Annals of oncology : official journal of the European Society for Medical Oncology, 22 5
E. Sturgis, P. Cinciripini (2007)
Trends in head and neck cancer incidence in relation to smoking prevalenceCancer, 110
Liselotte Dahlgren, H. Dahlstrand, D. Lindquist, A. Högmo, Linda Björnestål, J. Lindholm, Bertil Lundberg, T. Dalianis, E. Munck-Wikland (2004)
Human papillomavirus is more common in base of tongue than in mobile tongue cancer and is a favorable prognostic factor in base of tongue cancer patientsInternational Journal of Cancer, 112
J. Vermorken, A. Psyrri, R. Mesía, F. Peyrade, Frank Beier, B. Blas, I. Celik, L. Licitra (2014)
Impact of tumor HPV status on outcome in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck receiving chemotherapy with or without cetuximab: retrospective analysis of the phase III EXTREME trialAnnals of Oncology, 25
L. Surján (1988)
Immunohistochemical markers of tonsillar crypt epithelium.Acta oto-laryngologica. Supplementum, 454
Gilles Calais, Marc Alfonsi, E. Bardet, C. Sire, T. Germain, P. Bergerot, B. Rhein, J. Tortochaux, P. Oudinot, P. Bertrand (2000)
[Stage III and IV cancers of the oropharynx: results of a randomized study of Gortec comparing radiotherapy alone with concomitant chemotherapy].Bulletin du cancer, 87 Spec No
J. Cooper, K. Porter, K. Mallin, H. Hoffman, R. Weber, K. Ang, E. Gay, C. Langer (2009)
National Cancer Database report on cancer of the head and neck: 10‐Year updateHead & Neck, 31
M. Lawrence, C. Sougnez, Lee Lichtenstein, K. Cibulskis, E. Lander, S. Gabriel, G. Getz, Adrian Ally, M. Balasundaram, I. Birol, R. Bowlby, Denise Brooks, Y. Butterfield, R. Carlsen, Dean Cheng, Andy Chu, Noreen Dhalla, R. Guin, R. Holt, Steven Jones, Darlene Lee, H. Li, M. Marra, Michael Mayo, Richard Moore, A. Mungall, A. Robertson, J. Schein, Payal Sipahimalani, Angela Tam, N. Thiessen, Tina Wong, A. Protopopov, Netty Santoso, Semin Lee, Michael Parfenov, Jianhua Zhang, Harshad Mahadeshwar, Jiabin Tang, X. Ren, S. Seth, Psalm Haseley, Dong Zeng, Lixing Yang, A. Xu, Xingzhi Song, A. Pantazi, C. Bristow, Angela Hadjipanayis, J. Seidman, L. Chin, P. Park, R. Kucherlapati, R. Akbani, Tod Casasent, Wenbin Liu, Yiling Lu, G. Mills, Thomas Motter, J. Weinstein, L. Diao, Jing Wang, Youhong Fan, Jinze Liu, Kai Wang, J. Auman, S. Balu, T. Bodenheimer, Elizabeth Buda, D. Hayes, K. Hoadley, A. Hoyle, S. Jefferys, Corbin Jones, P. Kimes, Yufeng Liu, J. Marron, S. Meng, P. Mieczkowski, Lisle Mose, J. Parker, C. Perou, J. Prins, J. Roach, Yan Shi, J. Simons, Darshan Singh, Matthew Soloway, Donghui Tan, Umadevi Veluvolu, Vonn Walter, S. Waring, M. Wilkerson, Junyuan Wu, N. Zhao, A. Cherniack, P. Hammerman, A. Tward, C. Pedamallu, G. Saksena, Joonil Jung, A. Ojesina, S. Carter, Travis Zack, S. Schumacher, R. Beroukhim, S. Freeman, M. Meyerson, Juok Cho, M. Noble, D. Dicara, Hailei Zhang, David Heiman, N. Gehlenborg, Douglas Voet, Pei Lin, S. Frazer, P. Stojanov, Yingchun Liu, L. Zou, Jaegil Kim, D. Muzny, H. Doddapaneni, C. Kovar, J. Reid, Donna Morton, Yi Han, Walker Hale, H. Chao, K. Chang, J. Drummond, R. Gibbs, N. Kakkar, D. Wheeler, Liu Xi, G. Ciriello, M. Ladanyi, William Lee, Ricardo Ramirez, C. Sander, R. Shen, Rileen Sinha, Nils Weinhold, B. Taylor, B. Aksoy, Gideon Dresdner, Jianjiong Gao, Benjamin Gross, A. Jacobsen, B. Reva, N. Schultz, S. Sumer, Yichao Sun, T. Chan, L. Morris, Joshua Stuart, S. Benz, S. Ng, C. Benz, C. Yau, S. Baylin, L. Cope, Ludmila Danilova, J. Herman, M. Bootwalla, D. Maglinte, P. Laird, T. Triche, D. Weisenberger, D. Berg, N. Agrawal, J. Bishop, P. Boutros, J. Bruce, L. Byers, J. Califano, T. Carey, Zhong Chen, Hui Cheng, Simion Chiosea, E. Cohen, B. Diergaarde, A. Egloff, A. El-Naggar, R. Ferris, M. Frederick, J. Grandis, Yanzhu Guo, R. Haddad, Thomas Harris, A. Hui, J. Lee, S. Lippman, Fei-Fei Liu, J. Mchugh, J. Myers, P. Ng, B. Perez–Ordoñez, C. Pickering, M. Prystowsky, M. Romkes, Anthony Saleh, M. Sartor, R. Seethala, T. Seiwert, H. Si, C. Waes, Daryl Waggott, M. Wiznerowicz, W. Yarbrough, Jiexin Zhang, Zhixiang Zuo, K. Burnett, D. Crain, J. Gardner, Kevin Lau, D. Mallery, S. Morris, J. Paulauskis, R. Penny, C. Shelton, T. Shelton, M. Sherman, P. Yena, Aaron Black, Jay Bowen, J. Frick, J. Gastier-Foster, H. Harper, K. Leraas, T. Lichtenberg, N. Ramirez, L. Wise, E. Zmuda, J. Baboud, M. Jensen, A. Kahn, T. Pihl, D. Pot, Deepak Srinivasan, Jessica Walton, Yunhu Wan, R. Burton, Tanja Davidsen, John Demchok, G. Eley, M. Ferguson, K. Shaw, B. Ozenberger, Margi Sheth, H. Sofia, R. Tarnuzzer, Zhining Wang, Liming Yang, J. Zenklusen, Charles Saller, Katherine Tarvin, Chu Chen, R. Bollag, P. Weinberger, W. Golusiński, P. Golusiński, Matthew Ibbs, Konstanty Korski, A. Mackiewicz, W. Suchorska, Bartosz Szybiak, Erin Curley, C. Beard, Colleen Mitchell, G. Sandusky, Julie Ahn, Zubair Khan, J. Irish, J. Waldron, W. William, Sophie Egea, C. Gomez-Fernandez, Lynn Herbert, C. Bradford, D. Chepeha, Andrea Haddad, Tamara Jones, Christine Komarck, Mayya Malakh, J. Moyer, Ariane Nguyen, Lisa Peterson, M. Prince, L. Rozek, Evan Taylor, H. Walline, G. Wolf, L. Boice, B. Chera, W. Funkhouser, M. Gulley, T. Hackman, M. Hayward, Meijuan Huang, W. Rathmell, Ashley Salazar, W. Shockley, C. Shores, L. Thorne, M. Weissler, Sylvia Wrenn, A. Zanation, Brandee Brown, M. Pham (2015)
Comprehensive genomic characterization of head and neck squamous cell carcinomasNature, 517
C. Hobbs, J. Sterne, Michael Bailey, R. Heyderman, M. Birchall, Steve Thomas (2006)
Human papillomavirus and head and neck cancer: a systematic review and meta‐analysisClinical Otolaryngology, 31
CC Compton, FL Greene (2012)
AJCC cancer staging atlas: a companion to the seventh editions of the AJCC cancer staging manual and handbook
J. Rautava, S. Syrjänen (2012)
Biology of Human Papillomavirus Infections in Head and Neck CarcinogenesisHead and Neck Pathology, 6
A. Chaturvedi, E. Engels, W. Anderson, M. Gillison (2008)
Incidence trends for human papillomavirus-related and -unrelated oral squamous cell carcinomas in the United States.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 4
(2015)
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in womenN Engl J Med, 372
C. Fakhry, Barbara Rosenthal, D. Clark, M. Gillison (2011)
Associations between Oral HPV16 Infection and Cytopathology: Evaluation of an Oropharyngeal “Pap-Test Equivalent” in High-Risk PopulationsCancer Prevention Research, 4
E. Smith, J. Ritchie, K. Summersgill, J. Klussmann, John Lee, Donghong Wang, T. Haugen, L. Turek (2004)
Age, sexual behavior and human papillomavirus infection in oral cavity and oropharyngeal cancersInternational Journal of Cancer, 108
M. Gillison, W. Koch, R. Capone, M. Spafford, W. Westra, Li Wu, Marianna Zahurak, R. Daniel, M. Viglione, D. Symer, K. Shah, D. Sidransky (2000)
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers.Journal of the National Cancer Institute, 92 9
Mark Rolfe, P. Beer-Romero, S. Glass, Jens Eckstein, Ingrid Berdo, A. Theodoras, Michele Pagano, Giulio Draetta (1995)
Reconstitution of p53-ubiquitinylation reactions from purified components: the role of human ubiquitin-conjugating enzyme UBC4 and E6-associated protein (E6AP).Proceedings of the National Academy of Sciences of the United States of America, 92
D. Goldenberg, S. Begum, W. Westra, Zubair Khan, J. Sciubba, S. Pai, J. Califano, R. Tufano, W. Koch (2008)
Cystic lymph node metastasis in patients with head and neck cancer: An HPV‐associated phenomenonHead & Neck, 30
Maura Gillison, Tatevik Broutian, R. Pickard, Zhen-you Tong, W. Xiao, Lisa Kahle, Barry Graubard, Anil Chaturvedi (2012)
Prevalence of Oral HPV Infection in the United States , 2009-2010
K. Lindel, K. Beer, J. Laissue, R. Greiner, D. Aebersold (2001)
Human papillomavirus positive squamous cell carcinoma of the oropharynxCancer, 92
C. Fakhry, Ezra Cohen (2014)
The Rise of HPV-Positive Oropharyngeal Cancers in the United StatesCancer Prevention Research, 8
N. Agrawal, M. Frederick, C. Pickering, C. Bettegowda, K. Chang, Ryan Li, C. Fakhry, T. Xie, Jiexin Zhang, Jing Wang, Nianxiang Zhang, A. El-Naggar, S. Jasser, J. Weinstein, L. Treviño, J. Drummond, D. Muzny, Yuanqing Wu, L. Wood, R. Hruban, W. Westra, W. Koch, J. Califano, R. Gibbs, D. Sidransky, B. Vogelstein, V. Velculescu, N. Papadopoulos, D. Wheeler, K. Kinzler, J. Myers (2011)
Exome Sequencing of Head and Neck Squamous Cell Carcinoma Reveals Inactivating Mutations in NOTCH1Science, 333
C. Fakhry, W. Westra, Sigui Li, A. Cmelak, J. Ridge, H. Pinto, A. Forastiere, M. Gillison (2008)
Improved survival of patients with human papillomavirus-positive head and neck squamous cell carcinoma in a prospective clinical trial.Journal of the National Cancer Institute, 100 4
S. Um, N. Mundi, J. Yoo, D. Palma, K. Fung, D. MacNeil, B. Wehrli, J. Mymryk, J. Barrett, A. Nichols (2014)
Variable expression of the forgotten oncogene E5 in HPV-positive oropharyngeal cancer.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 61 1
M. Gillison (2004)
Human papillomavirus-associated head and neck cancer is a distinct epidemiologic, clinical, and molecular entity.Seminars in oncology, 31 6
E. Joura, A. Giuliano, O. Iversen, C. Bouchard, C. Mao, J. Mehlsen, E. Moreira, Y. Ngan, L. Petersen, E. Lazcano-Ponce, P. Pitisuttithum, J. Restrepo, G. Stuart, L. Woelber, Yuh Yang, J. Cuzick, S. Garland, W. Huh, S. Kjaer, Oliver Bautista, I. Chan, Joshua Chen, R. Gesser, E. Moeller, M. Ritter, S. Vuocolo, A. Luxembourg (2015)
A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women.Obstetrical & Gynecological Survey
(2012)
American Joint Committee on Cancer. AJCC cancer staging atlas: a companion to the seventh editions of the AJCC cancer staging manual and handbook
(2010)
Meta-analysis of the impact of human papillomavirus (HPV) on cancer risk and overall survival in head and neck squamous cell carcinomas (HNSCC)Head Neck Oncol., 2
S. Best, S. Peng, C. Juang, C. Hung, D. Hannaman, J. Saunders, T. Wu, S. Pai (2009)
Administration of HPV DNA vaccine via electroporation elicits the strongest CD8+ T cell immune responses compared to intramuscular injection and intradermal gene gun delivery.Vaccine, 27 40
R. Herrero, W. Quint, A. Hildesheim, Paula González, L. Struijk, H. Katki, C. Porras, M. Schiffman, A. Rodriguez, D. Solomon, Silvia Jiménez, J. Schiller, D. Lowy, L. Doorn, S. Wacholder, A. Kreimer (2013)
Reduced Prevalence of Oral Human Papillomavirus (HPV) 4 Years after Bivalent HPV Vaccination in a Randomized Clinical Trial in Costa RicaPLoS ONE, 8
M. Tornesello, F. Perri, L. Buonaguro, F. Ionna, F. Buonaguro, F. Caponigro (2014)
HPV-related oropharyngeal cancers: from pathogenesis to new therapeutic approaches.Cancer letters, 351 2
H. Hausen (1994)
Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types.Current topics in microbiology and immunology, 186
K. Ang, E. Sturgis (2012)
Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma.Seminars in radiation oncology, 22 2
(2011)
The molecular biology of head and neck cancerNat Rev Cancer, 11
S. Marur, G. D’Souza, W. Westra, A. Forastiere (2010)
HPV-associated head and neck cancer: a virus-related cancer epidemic.The Lancet. Oncology, 11 8
L. Masterson, D. Moualed, Z. Liu, James Howard, Raghav Dwivedi, J. Tysome, Richard Benson, J. Sterling, H. Sudhoff, P. Jani, P. Goon (2014)
De-escalation treatment protocols for human papillomavirus-associated oropharyngeal squamous cell carcinoma: a systematic review and meta-analysis of current clinical trials.European journal of cancer, 50 15
N. Upile, R. Shaw, T. Jones, P. Goodyear, T. Liloglou, J. Risk, M. Boyd, J. Sheard, P. Sloan, M. Robinson, A. Schache (2014)
Squamous cell carcinoma of the head and neck outside the oropharynx is rarely human papillomavirus relatedThe Laryngoscope, 124
G. Han, Shi-Long Lu, Allen Li, Wei He, C. Corless, M. Kulesz-Martin, Xiao-Jing Wang (2005)
Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis.The Journal of clinical investigation, 115 7
K. Strati, P. Lambert (2008)
HUMAN PAPILLOMAVIRUS ASSOCIATION WITH HEAD AND NECK CANCERS: UNDERSTANDING VIRUS BIOLOGY AND USING IT IN THE DEVELOPMENT OF CANCER DIAGNOSTICS.Expert opinion on medical diagnostics, 2 1
M. Kershaw, J. Westwood, C. Slaney, P. Darcy (2014)
Clinical application of genetically modified T cells in cancer therapyClinical & Translational Immunology, 3
A. Kreimer, Rohini Bhatia, Andrea Messeguer, Paula González, R. Herrero, A. Giuliano (2010)
Oral Human Papillomavirus in Healthy Individuals: A Systematic Review of the LiteratureSexually Transmitted Diseases, 37
J. Bonner, P. Harari, J. Giralt, N. Azarnia, D. Shin, R. Cohen, Christopher Jones, R. Sur, D. Raben, J. Jassem, R. Ove, M. Kies, J. Baselga, H. Youssoufian, N. Amellal, E. Rowinsky, E. Rowinsky, K. Ang (2006)
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.The New England journal of medicine, 354 6
K. Syrjänen, K. Syrjänen, S. Syrjänen, S. Syrjänen, M. Lamberg, M. Lamberg, S. Pyrhönen, S. Pyrhönen, Juhant Nuutinen, Juhant Nuutinen (1983)
Morphological and immunohistochemical evidence suggesting human papillomavirus (HPV) involvement in oral squamous cell carcinogenesis.International journal of oral surgery, 12 6
B. Kofler, S. Laban, C. Busch, B. Lörincz, R. Knecht (2014)
New treatment strategies for HPV-positive head and neck cancerEuropean Archives of Oto-Rhino-Laryngology, 271
J. Guily, A. Jacquard, J. Prétet, J. Haesebaert, A. Beby‐Defaux, C. Clavel, G. Agius, P. Birembaut, C. Okaïs, Y. Léocmach, B. Soubeyrand, P. Pradat, D. Riethmuller, C. Mougin, F. Denis (2011)
Human papillomavirus genotype distribution in oropharynx and oral cavity cancer in France--The EDiTH VI study.Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology, 51 2
Brachman Dg (1994)
Molecular biology of head and neck cancer.Seminars in oncology, 21 3
M. Gillison, Tatevik Broutian, R. Pickard, Zhen-you Tong, W. Xiao, L. Kahle, B. Graubard, A. Chaturvedi (2012)
Prevalence of oral HPV infection in the United States, 2009-2010.JAMA, 307 7
W. Steiner (1988)
Experience in endoscopic laser surgery of malignant tumours of the upper aero-digestive tract.Advances in oto-rhino-laryngology, 39
C. Fakhry, M. Gillison, G. D’Souza (2014)
Tobacco use and oral HPV-16 infection.JAMA, 312 14
C. Allen, J. Lewis, S. El-Mofty, B. Haughey, B. Nussenbaum (2010)
Human papillomavirus and oropharynx cancer: Biology, detection and clinical implicationsThe Laryngoscope, 120
A. Mishra, A. Bharti, P. Varghese, D. Saluja, B. Das (2006)
Differential expression and activation of NF‐κB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infectionInternational Journal of Cancer, 119
A. Kreimer, M. Johansson, T. Waterboer, R. Kaaks, J. Chang-Claude, Dagmar Drogen, A. Tjønneland, K. Overvad, J. Quirós, C. González, María-José Sánchez, N. Larranaga, C. Navarro, A. Barricarte, R. Travis, K. Khaw, N. Wareham, A. Trichopoulou, A. Trichopoulou, P. Lagiou, P. Lagiou, P. Lagiou, D. Trichopoulos, P. Peeters, S. Panico, G. Masala, S. Grioni, R. Tumino, P. Vineis, H. Bueno-de-Mesquita, G. Laurell, G. Hallmans, J. Manjer, Johanna Ekström, G. Skeie, E. Lund, E. Weiderpass, P. Ferrari, G. Byrnes, I. Romieu, E. Riboli, A. Hildesheim, H. Boeing, M. Pawlita, P. Brennan (2013)
Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31 21
A. Mishra, A. Bharti, P. Varghese, D. Saluja, B. Das (2006)
Differential expression and activation of NF-kappaB family proteins during oral carcinogenesis: Role of high risk human papillomavirus infection.International journal of cancer, 119 12
B. Haughey, M. Hinni, J. Salassa, R. Hayden, D. Grant, Jason Rich, Simon Milov, J. Lewis, M. Krishna (2011)
Transoral laser microsurgery as primary treatment for advanced‐stage oropharyngeal cancer: A united states multicenter studyHead & Neck, 33
D. Zandberg, S. Rollins, O. Goloubeva, R. Morales, M. Tan, Rodney Taylor, J. Wolf, L. Schumaker, K. Cullen, A. Zimrin, R. Ord, J. Lubek, M. Suntharalingam, J. Papadimitriou, D. Mann, S. Strome, M. Edelman (2015)
A phase I dose escalation trial of MAGE-A3- and HPV16-specific peptide immunomodulatory vaccines in patients with recurrent/metastatic (RM) squamous cell carcinoma of the head and neck (SCCHN)Cancer Immunology, Immunotherapy, 64
M. Poeta, M. Poeta, J. Manola, Meredith Goldwasser, A. Forastiere, N. Benoit, J. Califano, J. Ridge, J. Goodwin, D. Kenady, John Saunders, W. Westra, D. Sidransky, Wayne Koch (2007)
TP53 mutations and survival in squamous-cell carcinoma of the head and neck.The New England journal of medicine, 357 25
E. Riboli, K. Hunt, N. Slimani, P. Ferrari, T. Norat, M. Fahey, U. Charrondière, Bertrand Hémon, C. Casagrande, J. Vignat, K. Overvad, A. Tjønneland, F. Clavel-Chapelon, Anne Thiébaut, J. Wahrendorf, H. Boeing, D. Trichopoulos, D. Trichopoulos, A. Trichopoulou, P. Vineis, D. Palli, H. Bueno-de-Mesquita, P. Peeters, E. Lund, D. Engeset, C. González, A. Barricarte, G. Berglund, G. Hallmans, N. Day, T. Key, R. Kaaks, R. Saracci (2002)
European Prospective Investigation into Cancer and Nutrition (EPIC): study populations and data collectionPublic Health Nutrition, 5
C. Compton, D. Byrd, J. García-Aguilar, S. Kurtzman, A. Olawaiye, M. Washington (2006)
AJCC cancer staging atlas
A. Kreimer (2014)
Prospects for prevention of HPV-driven oropharynx cancer.Oral oncology, 50 6
W. Mydlarz, J. Chan, J. Richmon (2015)
The role of surgery for HPV-associated head and neck cancer.Oral oncology, 51 4
A. Kreimer, G. Clifford, P. Boyle, S. Franceschi (2005)
Human Papillomavirus Types in Head and Neck Squamous Cell Carcinomas Worldwide: A Systematic ReviewCancer Epidemiology Biomarkers & Prevention, 14
R. Kirnbauer, F. Booy, N. Cheng, D. Lowy, J. Schiller (1992)
Papillomavirus L1 major capsid protein self-assembles into virus-like particles that are highly immunogenic.Proceedings of the National Academy of Sciences of the United States of America, 89 24
Nicolas Stransky, A. Egloff, Aaron Tward, Aleksandar Kostic, K. Cibulskis, A. Sivachenko, G. Kryukov, M. Lawrence, C. Sougnez, A. McKenna, Erica Shefler, A. Ramos, P. Stojanov, S. Carter, Douglas Voet, M. Cortés, Daniel Auclair, Michael Berger, G. Saksena, C. Guiducci, R. Onofrio, Melissa Parkin, M. Romkes, J. Weissfeld, Raja Seethala, Lin Wang, C. Rangel-Escareño, J. Fernández-López, A. Hidalgo-Miranda, J. Meléndez-Zajgla, W. Winckler, K. Ardlie, S. Gabriel, M. Meyerson, Eric Lander, G. Getz, Todd Golub, Levi Garraway, J. Grandis (2011)
The Mutational Landscape of Head and Neck Squamous Cell CarcinomaScience, 333
M. Rietbergen, P. Snijders, Derakshan Beekzada, B. Braakhuis, A. Brink, Daniëlle Heideman, A. Hesselink, Birgit Witte, E. Bloemena, E. Bloemena, R. Jong, C. Leemans, R. Brakenhoff (2014)
Molecular characterization of p16‐immunopositive but HPV DNA‐negative oropharyngeal carcinomasInternational Journal of Cancer, 134
Ketaki Ganti, J. Broniarczyk, W. Manoubi, P. Massimi, S. Mittal, D. Pim, Anita Szalmás, Jayashree Thatte, Miranda Thomas, V. Tomaić, L. Banks (2015)
The Human Papillomavirus E6 PDZ Binding Motif: From Life Cycle to MalignancyViruses, 7
Kate Kelly, S. Johnson-Obaseki, Julienne Lumingu, M. Corsten (2014)
Oncologic, functional and surgical outcomes of primary Transoral Robotic Surgery for early squamous cell cancer of the oropharynx: a systematic review.Oral oncology, 50 8
J. Schiller, X. Castellsagué, S. Garland (2012)
A review of clinical trials of human papillomavirus prophylactic vaccines.Vaccine, 30 Suppl 5
A. Carvalho, I. Nishimoto, J. Califano, L. Kowalski (2005)
Trends in incidence and prognosis for head and neck cancer in the United States: A site‐specific analysis of the SEER databaseInternational Journal of Cancer, 114
G. Lescaille, F. Pitoiset, Rodney Macedo, C. Baillou, Christophe Huret, D. Klatzmann, E. Tartour, F. Lemoine, B. Bellier (2013)
Efficacy of DNA vaccines forming e7 recombinant retroviral virus-like particles for the treatment of human papillomavirus-induced cancers.Human gene therapy, 24 5
J. Bishop, J. Lewis, J. Rocco, W. Faquin (2015)
HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice.Seminars in diagnostic pathology, 32 5
Se-Heon Kim, B. Koo, Suki Kang, Kyeongmee Park, Haeryoung Kim, Kyung Lee, Moo-Joo Lee, Jong Kim, E. Choi, N. Cho (2007)
HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c‐myc during tumor formationInternational Journal of Cancer, 120
J. Vermorken, J. Stöhlmacher-Williams, I. Davidenko, L. Licitra, E. Winquist, C. Villanueva, P. Foa, S. Rottey, K. Składowski, M. Tahara, V. Pai, S. Faivre, C. Blajman, A. Forastiere, B. Stein, K. Oliner, Zhiying Pan, B. Bach (2013)
Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial.The Lancet. Oncology, 14 8
A. Chaturvedi, E. Engels, R. Pfeiffer, B. Hernandez, W. Xiao, Esther Kim, B. Jiang, M. Goodman, M. Sibug-Saber, W. Cozen, Lihua Liu, C. Lynch, N. Wentzensen, R. Jordan, S. Altekruse, W. Anderson, P. Rosenberg, M. Gillison (2014)
J OURNAL OF C LINICAL O NCOLOGY Human Papillomavirus and Rising Oropharyngeal Cancer Incidence in the United StatesJournal of Clinical Oncology, 29
S. Dowthwaite, J. Franklin, D. Palma, K. Fung, J. Yoo, A. Nichols (2012)
The Role of Transoral Robotic Surgery in the Management of Oropharyngeal Cancer: A Review of the LiteratureISRN Oncology, 2012
Kath Wright, K. Light, L. Stirk (2008)
Open Access ResearchJournal of Health Services Research & Policy, 16
C. Chung, A. Bagheri, G. D’Souza (2014)
Epidemiology of oral human papillomavirus infection.Oral oncology, 50 5
S. Shafti-Keramat, A. Handisurya, E. Kriehuber, G. Meneguzzi, Katharina Slupetzky, R. Kirnbauer (2003)
Different Heparan Sulfate Proteoglycans Serve asCellular Receptors for HumanPapillomavirusesJournal of Virology, 77
A. Hong, A. Martin, M. Chatfield, Deanna Jones, Mei Zhang, B. Armstrong, C. Lee, G. Harnett, C. Milross, Jonathan Clark, M. Elliott, R. Smee, J. Corry, Chen Liu, S. Porceddu, G. Rees, B. Rose (2013)
Human papillomavirus, smoking status and outcomes in tonsillar squamous cell carcinomaInternational Journal of Cancer, 132
M. Machtay, J. Moughan, A. Trotti, A. Garden, Randal Weber, Jay Cooper, A. Forastiere, K. Ang (2008)
Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: an RTOG analysis.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 26 21
PhD MD, S. Dogan, F. Ba, R. Rahmati, I. Nixon, N. Lee, S. Patel, J. Shah, PhD MD (2015)
Detailed Analysis of Clinicopathologic Factors Demonstrate Distinct Difference in Outcome and Prognostic Factors Between Surgically Treated HPV-Positive and Negative Oropharyngeal CancerAnnals of Surgical Oncology, 22
T. Rampias, C. Sasaki, A. Psyrri (2014)
Molecular mechanisms of HPV induced carcinogenesis in head and neck.Oral oncology, 50 5
B. Lörincz, N. Jowett, R. Knecht (2016)
Decision management in transoral robotic surgery: Indications, individual patient selection, and role in the multidisciplinary treatment for head and neck cancer from a European perspectiveHead & Neck, 38
(zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol. 1994;186:131–56.)
zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol. 1994;186:131–56.zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol. 1994;186:131–56., zur Hausen H. Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types. Curr Top Microbiol Immunol. 1994;186:131–56.
K. Pytynia, Kristina Dahlstrom, E. Sturgis (2014)
Epidemiology of HPV-associated oropharyngeal cancer.Oral oncology, 50 5
F. Keane, Yui‐Hui Chen, B. Neville, R. Tishler, J. Schoenfeld, P. Catalano, D. Margalit (2015)
Changing prognostic significance of tumor stage and nodal stage in patients with squamous cell carcinoma of the oropharynx in the human papillomavirus eraCancer, 121
M. Gillison, G. D’Souza, W. Westra, E. Sugar, W. Xiao, S. Begum, R. Viscidi (2008)
Distinct risk factor profiles for human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck cancers.Journal of the National Cancer Institute, 100 6
D. Winn, Y. Lee, M. Hashibe, P. Boffetta, A. Agudo, W. Ahrens, V. Bencko, S. Benhamou, Stefania Boccia, C. Bosetti, P. Brennan, H. Brenner, G. Cadoni, X. Castellsagué, Chu Chen, D. Conway, M. Curado, G. D’Souza, L. Maso, A. Daudt, K. Ruyck, B. Diergaarde, J. Eluf-Neto, E. Fabiánová, L. Fernandez, S. Franceschi, M. Gillison, R. Haddad, R. Hayes, C. Healy, R. Herrero, J. Hofmann, I. Holcatova, R. Hung, K. Kelsey, K. Kjærheim, S. Koifman, C. Vecchia, M. Lacko, P. Lagiou, P. Lazarus, F. Levi, Guojun Li, J. Lissowska, Geoffrey Liu, D. Luce, T. Macfarlane, M. Mahimkar, D. Mates, K. Matsuo, M. McClean, Ana Menezes, G. Menvielle, F. Merletti, K. Moysich, J. Muscat, A. Olshan, M. Pawlita, W. Peters, H. Ramroth, L. Rozek, P. Rudnai, S. Schantz, Steve Schwartz, D. Serraino, O. Shangina, L. Simonato, E. Smith, I. Stücker, E. Sturgis, N. Szeszenia‐Da̧browska, Peter Thomson, T. Vaughan, M. Vilensky, G. Wolf, V. Wünsch-Filho, Guo-Pei Yu, D. Zaridze, W. Zatoński, J. Zevallos, Zuo‐Feng Zhang, T. Zheng, A. Znaor (2015)
The INHANCE consortium: toward a better understanding of the causes and mechanisms of head and neck cancer.Oral diseases, 21 6
D. Fein, W.Robert Lee, Warren Amos, R. Hinerman, J. Parsons, W. Mendenhall, S. Stringer, N. Cassisi, R. Million (1996)
Oropharyngeal carcinoma treated with radiotherapy: a 30-year experience.International journal of radiation oncology, biology, physics, 34 2
H. Mellin, S. Friesland, R. Lewensohn, T. Dalianis, E. Munck-Wikland (2000)
Human papillomavirus (HPV) DNA in tonsillar cancer: Clinical correlates, risk of relapse, and survivalInternational Journal of Cancer, 89
G. D’Souza, A. Kreimer, R. Viscidi, M. Pawlita, C. Fakhry, W. Koch, W. Westra, M. Gillison (2007)
Case-control study of human papillomavirus and oropharyngeal cancer.The New England journal of medicine, 356 19
Shama Kajiji, R. Tamura, Vito Quaranta (1989)
A novel integrin (alpha E beta 4) from human epithelial cells suggests a fourth family of integrin adhesion receptors.The EMBO Journal, 8
J. Almeida, J. Byrd, R. Wu, C. Stucken, U. Duvvuri, D. Goldstein, B. Miles, M. Teng, Vishal Gupta, E. Genden (2014)
A systematic review of transoral robotic surgery and radiotherapy for early oropharynx cancer: A systematic reviewThe Laryngoscope, 124
J. Shah, S. Patel, Bhuvanesh Singh (2012)
Jatin Shah's head and neck surgery and oncology
M. Pogorzelski, S. Ting, T. Gauler, F. Breitenbuecher, I. Vossebein, S. Hoffarth, J. Markowetz, S. Lang, C. Bergmann, S. Brandau, J. Jawad, K. Schmid, M. Schuler, S. Kasper (2014)
Impact of human papilloma virus infection on the response of head and neck cancers to anti-epidermal growth factor receptor antibody therapyCell Death & Disease, 5
H. Mirghani, F. Amen, F. Moreau, J. Guigay, Dana Hartl, J. Guily (2014)
Oropharyngeal cancers: relationship between epidermal growth factor receptor alterations and human papillomavirus status.European journal of cancer, 50 6
(Cancer IAfRo. Monograph volume 90: WHO. 2007. Available from: (http://monographs.iarc.fr). Cited 2015.)
Cancer IAfRo. Monograph volume 90: WHO. 2007. Available from: (http://monographs.iarc.fr). Cited 2015.Cancer IAfRo. Monograph volume 90: WHO. 2007. Available from: (http://monographs.iarc.fr). Cited 2015., Cancer IAfRo. Monograph volume 90: WHO. 2007. Available from: (http://monographs.iarc.fr). Cited 2015.
A. Chaturvedi, W. Anderson, J. Lortet-Tieulent, M. Curado, J. Ferlay, S. Franceschi, P. Rosenberg, F. Bray, M. Gillison (2013)
Worldwide trends in incidence rates for oral cavity and oropharyngeal cancers.Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 31 36
Oropharyngeal cancers caused by human papillomaviruses (HPV) have a different epidemiology, prognosis, genetic mutational landscape, response to treatment, and outcome when compared to HPV-negative cancers. In this review, a summary of our current understanding of HPV in head and neck cancer and the important advances that have shown HPV to be an etiological agent are discussed. HPV-positive and HPV-negative tumors are compared discussing clinicopathological factors, prognosis, outcome following treatment, and the molecular and genetic differences. Currently, the standard of care for oropharyngeal cancer is both surgery and post-operative radiotherapy with or without cisplatin or concurrent chemo-radiotherapy. The latter is used more often, especially in cancers of tonsil and base of tongue. However, there is increased interest in trying to de-intensify treatment and in the development of new treatments to target the underlying different molecular pathways of HPV-positive cancers. The current clinical trials involving surgery, chemotherapy, and radiation therapy are discussed. The new targeted treatments are also summarized. Although there is currently is no evidence from prospective studies to support a change in the treatment algorithm, the treatment options for patients with HPV-positive disease are likely to change in the future.
Oncology and Therapy – Springer Journals
Published: Sep 9, 2015
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.